jmrenal.bsky.social
@jmrenal.bsky.social
Some important trials for drugs targeting 3 different pathways in IgAN: supportive (anti-proteinuric), Gd-IgA1 reduction and anti-inflammatory.
November 22, 2024 at 9:47 PM